Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: AktieTorget
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

CONPB:SS

0.7600 SEK 0.00000.00%

As of 13:00:01 ET on 03/25/2015.

Snapshot for Conpharm AB (CONPB)

Open: 0.7450 Day's Range: 0.7450 - 0.7600 Volume: 4,000
Previous Close: 0.7600 52wk Range: 0.4100 - 0.9500 1-Yr Rtn: +4.11%

Stock Chart for CONPB

No chart data available.
  • CONPB:SS 0.7600
  • 1D
  • 1M
  • 1Y
0.7600
Interactive CONPB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CONPB

Current P/E Ratio (ttm) 2.0994
Estimated P/E(-) -
Relative P/E vs. OMX 0.1173
Earnings Per Share (ttm) 0.3620
Est. EPS -
Est. PEG Ratio -
Market Cap (M SEK) 19.39
Shares Outstanding (M) 17.50
30 Day Average Volume 19,685
Price/Book (mrq) 0.7196
Price/Sale (ttm) 2.4955
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/26/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CONPB

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for CONPB

Conpharm AB is a pharmaceutical company. The Company develops and markets, through licensees, pharmaceutical products based on substances extracted from the Podyphyllum plant. Conpharm's product line includes Wartec, for the treatment of warts, and Reumacon used to treat rheumatoid arthritis. The Company markets its products worldwide.

Jakob OesterbergChief Executive Officer
More Company Profile & Key Executives for CONPB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil